Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Symons

Showing results (231-240 of 248) with videos related to

Pageof 25
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 18, 2018
Early Fever after Haploidentical Bone Marrow Transplantation Correlates with Class II HLA-Mismatching and Myeloablation but Not OutcomesShannon R McCurdy, Stephen T Muth, Hua-Ling Tsai, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 27, 2016
Nonmyeloablative Haploidentical Bone Marrow Transplantation with Post-Transplantation Cyclophosphamide for Pediatric and Young Adult Patients with High-Risk Hematologic MalignanciesOrly R Klein, Jessica Buddenbaum, Noah Tucker, et al.
Transplantation and Cellular Therapy|November 7, 2025
Long-Term Follow-Up of the Baltimore Experience with Hematopoietic Cell Transplantation for Severe Aplastic Anemia Using Post-Transplantation CyclophosphamideAmy E DeZern, Marianna Zahurak, Tyler Cavin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 21, 2008
HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamideLeo Luznik, Paul V O'Donnell, Heather J Symons, et al.
Pain|June 24, 2025
Over 50 years of research on social disparities in pain and pain treatment: a scoping review of reviewsHanna Grol-Prokopczyk, Rui Huang, Chang Yu, et al.
Blood Advances|June 9, 2026
Donor-Specific Transplant Outcomes from BMTCTN 1702: A Multi-Center Prospective Biological-Assignment TrialAsad Bashey, Brent R Logan, LaQuisa C Hill, et al.
Haematologica|November 16, 2016
Comparable composite endpoints after HLA-matched and HLA-haploidentical transplantation with post-transplantation cyclophosphamideShannon R McCurdy, Yvette L Kasamon, Christopher G Kanakry, et al.
Blood|March 28, 2015
Risk-stratified outcomes of nonmyeloablative HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamideShannon R McCurdy, Jennifer A Kanakry, Margaret M Showel, et al.
Physical Review Letters|April 6, 2001
Directed flow of lambda hyperons in (2-6 )A GeV Au+Au collisionsP Chung, N N Ajitanand, J M Alexander, et al.
Physical Review Letters|September 5, 2001
Model-independent source imaging using two-pion correlations in (2 to 8)a GeV Au+Au collisionsS Y Panitkin, N N Ajitanand, J Alexander, et al.
Pageof 25

Showing results (231-240 of 248) with videos related to

Sort By:
Pageof 25
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 18, 2018
Early Fever after Haploidentical Bone Marrow Transplantation Correlates with Class II HLA-Mismatching and Myeloablation but Not OutcomesShannon R McCurdy, Stephen T Muth, Hua-Ling Tsai, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 27, 2016
Nonmyeloablative Haploidentical Bone Marrow Transplantation with Post-Transplantation Cyclophosphamide for Pediatric and Young Adult Patients with High-Risk Hematologic MalignanciesOrly R Klein, Jessica Buddenbaum, Noah Tucker, et al.
Transplantation and Cellular Therapy|November 7, 2025
Long-Term Follow-Up of the Baltimore Experience with Hematopoietic Cell Transplantation for Severe Aplastic Anemia Using Post-Transplantation CyclophosphamideAmy E DeZern, Marianna Zahurak, Tyler Cavin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 21, 2008
HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamideLeo Luznik, Paul V O'Donnell, Heather J Symons, et al.
Pain|June 24, 2025
Over 50 years of research on social disparities in pain and pain treatment: a scoping review of reviewsHanna Grol-Prokopczyk, Rui Huang, Chang Yu, et al.
Blood Advances|June 9, 2026
Donor-Specific Transplant Outcomes from BMTCTN 1702: A Multi-Center Prospective Biological-Assignment TrialAsad Bashey, Brent R Logan, LaQuisa C Hill, et al.
Haematologica|November 16, 2016
Comparable composite endpoints after HLA-matched and HLA-haploidentical transplantation with post-transplantation cyclophosphamideShannon R McCurdy, Yvette L Kasamon, Christopher G Kanakry, et al.
Blood|March 28, 2015
Risk-stratified outcomes of nonmyeloablative HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamideShannon R McCurdy, Jennifer A Kanakry, Margaret M Showel, et al.
Physical Review Letters|April 6, 2001
Directed flow of lambda hyperons in (2-6 )A GeV Au+Au collisionsP Chung, N N Ajitanand, J M Alexander, et al.
Physical Review Letters|September 5, 2001
Model-independent source imaging using two-pion correlations in (2 to 8)a GeV Au+Au collisionsS Y Panitkin, N N Ajitanand, J Alexander, et al.
Pageof 25